Sanguine Biosciences Company
Sanguine Biosciences is a pioneer of in-home specimen collection and a leader in direct-to-patient recruitment and digital health innovation. They partner with researchers on their study designs and support cross-sectional and longitudinal analyses with complex patient inclusion/exclusion sample collection criteria.
Industry:
Genomic and Epigenominc Instabillity
Headquarters:
United States
Register and Claim Ownership